The table below shows FENNEC PHARMACEUTICALS INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$15.11M
$12.46M
$9.65M
$8.75M
$6.97M
$7.26M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$49.00K
$29.00K
$107.00K
$94.00K
$97.00K
$157.00K
SG&A
FENC annual revenue (10-K history)
FENNEC PHARMACEUTICALS INC. reported annual revenue of $44.64M for fiscal year 2025. That is down 6.1% from $47.54M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.